These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1328 related items for PubMed ID: 17054926

  • 21. TLR4 signaling induced TLR2 expression in the process of mimic cerebral ischemia/reperfusion in vitro.
    Sun P, Zhang Q, Han J, Tian Y, Zhang J.
    Sci China Life Sci; 2010 Feb; 53(2):223-8. PubMed ID: 20596831
    [Abstract] [Full Text] [Related]

  • 22. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
    Mudaliar H, Pollock C, Komala MG, Chadban S, Wu H, Panchapakesan U.
    Am J Physiol Renal Physiol; 2013 Jul 15; 305(2):F143-54. PubMed ID: 23576640
    [Abstract] [Full Text] [Related]

  • 23. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
    Langlet C, Springael C, Johnson J, Thomas S, Flamand V, Leitges M, Goldman M, Aksoy E, Willems F.
    Eur J Immunol; 2010 Feb 15; 40(2):505-15. PubMed ID: 19950169
    [Abstract] [Full Text] [Related]

  • 24. Cultured astrocytes express toll-like receptors for bacterial products.
    Bowman CC, Rasley A, Tranguch SL, Marriott I.
    Glia; 2003 Sep 15; 43(3):281-91. PubMed ID: 12898707
    [Abstract] [Full Text] [Related]

  • 25. MyD88-dependent nuclear factor-kappaB activation is involved in fibrinogen-induced hypertrophic response of cardiomyocytes.
    Li T, Wang Y, Liu C, Hu Y, Wu M, Li J, Guo L, Chen L, Chen Q, Ha T, Li C, Li Y.
    J Hypertens; 2009 May 15; 27(5):1084-93. PubMed ID: 19342961
    [Abstract] [Full Text] [Related]

  • 26. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
    Sawaki J, Tsutsui H, Hayashi N, Yasuda K, Akira S, Tanizawa T, Nakanishi K.
    Int Immunol; 2007 Mar 15; 19(3):311-20. PubMed ID: 17289654
    [Abstract] [Full Text] [Related]

  • 27. Differential immune effects mediated by Toll-like receptors stimulation in precursor B-cell acute lymphoblastic leukaemia.
    Corthals SL, Wynne K, She K, Shimizu H, Curman D, Garbutt K, Reid GS.
    Br J Haematol; 2006 Feb 15; 132(4):452-8. PubMed ID: 16412017
    [Abstract] [Full Text] [Related]

  • 28. Brucella abortus induces Irgm3 and Irga6 expression via type-I IFN by a MyD88-dependent pathway, without the requirement of TLR2, TLR4, TLR5 and TLR9.
    Lapaque N, Muller A, Alexopoulou L, Howard JC, Gorvel JP.
    Microb Pathog; 2009 Dec 15; 47(6):299-304. PubMed ID: 19747534
    [Abstract] [Full Text] [Related]

  • 29. 34 kDa MOMP of Shigella flexneri promotes TLR2 mediated macrophage activation with the engagement of NF-kappaB and p38 MAP kinase signaling.
    Pore D, Mahata N, Pal A, Chakrabarti MK.
    Mol Immunol; 2010 May 15; 47(9):1739-46. PubMed ID: 20347487
    [Abstract] [Full Text] [Related]

  • 30. IFNs activate toll-like receptor gene expression in viral infections.
    Miettinen M, Sareneva T, Julkunen I, Matikainen S.
    Genes Immun; 2001 Oct 15; 2(6):349-55. PubMed ID: 11607792
    [Abstract] [Full Text] [Related]

  • 31. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells.
    Smith MF, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K, Crowe S, Goldberg JB.
    J Biol Chem; 2003 Aug 29; 278(35):32552-60. PubMed ID: 12807870
    [Abstract] [Full Text] [Related]

  • 32. Essential role of Toll-like receptor 2 in macrophage activation by glycogen.
    Kakutani R, Adachi Y, Takata H, Kuriki T, Ohno N.
    Glycobiology; 2012 Jan 29; 22(1):146-59. PubMed ID: 21873606
    [Abstract] [Full Text] [Related]

  • 33. Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion.
    Bieneman AP, Chichester KL, Chen YH, Schroeder JT.
    J Allergy Clin Immunol; 2005 Feb 29; 115(2):295-301. PubMed ID: 15696084
    [Abstract] [Full Text] [Related]

  • 34. Toll-like receptor 4 signalling is specifically TGF-beta-activated kinase 1 independent in synovial fibroblasts.
    Geurts J, van den Brand BT, Wolf A, Abdollahi-Roodsaz S, Arntz OJ, Kracht M, van den Berg WB, van de Loo FA.
    Rheumatology (Oxford); 2011 Jul 29; 50(7):1216-25. PubMed ID: 21335610
    [Abstract] [Full Text] [Related]

  • 35. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB.
    Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB.
    Immunity; 2007 May 29; 26(5):605-16. PubMed ID: 17462920
    [Abstract] [Full Text] [Related]

  • 36. The TLR2 ligand FSL-1 and the TLR5 ligand Flagellin mediate pro-inflammatory and pro-labour response via MyD88/TRAF6/NF-κB-dependent signalling.
    Lim R, Barker G, Lappas M.
    Am J Reprod Immunol; 2014 May 29; 71(5):401-17. PubMed ID: 24635133
    [Abstract] [Full Text] [Related]

  • 37. Chlamydophila pneumoniae induces expression of toll-like receptor 4 and release of TNF-alpha and MIP-2 via an NF-kappaB pathway in rat type II pneumocytes.
    Wissel H, Schulz C, Koehne P, Richter E, Maass M, Rüdiger M.
    Respir Res; 2005 Jun 03; 6(1):51. PubMed ID: 15935092
    [Abstract] [Full Text] [Related]

  • 38. TLR2, TLR3 and TLR5 regulation of pro-inflammatory and pro-labour mediators in human primary myometrial cells.
    Lim R, Barker G, Lappas M.
    J Reprod Immunol; 2017 Aug 03; 122():28-36. PubMed ID: 28844021
    [Abstract] [Full Text] [Related]

  • 39. Protein tyrosine phosphatase with proline-glutamine-serine-threonine-rich motifs negatively regulates TLR-triggered innate responses by selectively inhibiting IκB kinase β/NF-κB activation.
    Zhang P, Liu X, Li Y, Zhu X, Zhan Z, Meng J, Li N, Cao X.
    J Immunol; 2013 Feb 15; 190(4):1685-94. PubMed ID: 23296707
    [Abstract] [Full Text] [Related]

  • 40. Toll-like receptors TLR2 and TLR4 initiate the innate immune response of the renal tubular epithelium to bacterial products.
    Chowdhury P, Sacks SH, Sheerin NS.
    Clin Exp Immunol; 2006 Aug 15; 145(2):346-56. PubMed ID: 16879256
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 67.